SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Henley Health Care (HENL)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dick Jaffe who wrote (31)9/8/1997 7:53:00 PM
From: Dick Jaffe   of 89
 
I have seen many estimates that carpal tunnel syndrome costs American industry upwards of $100 billion annually in workman's comp claims. Here we have a little company that owns the worldwide distribution rights to the MicroLite 830 which just about cures 75% of the people who suffer from this problem . . . and it does it with just a few non-invasive, non-side effect, treatments with its cold laser.

C'mon folks, when the FDA gets off its dead a** and approves this device, this company is going to the MOON! Meanwhile their superb management has made it a profitable company by acquisition. They are now the second largest medical rehab products company in the country.

Don't kick yourself when this stock passes $10 on its way north.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News